Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells

Melchiorre Cervello(Foundation for Biomedical Research), Giuseppe Montalto(University of Palermo)

PLoS ONE

June 12, 2013

10.1371/journal.pone.0065569

Cited by 50

Related Papers

NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance

|Cell Death and Disease|2016|141

Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation

|International Journal of Oncology|2017|94

Nanostructured Lipid Carriers-Containing Anticancer Compounds: Preparation, Characterization, and Cytotoxicity Studies

|Drug Delivery|2007|72

Daily Use of Extra Virgin Olive Oil with High Oleocanthal Concentration Reduced Body Weight, Waist Circumference, Alanine Transaminase, Inflammatory Cytokines and Hepatic Steatosis in Subjects with the Metabolic Syndrome: A 2-Month Intervention Study

|Metabolites|2020|57

Liraglutide Increases Serum Levels of MicroRNA-27b, -130a and -210 in Patients with Type 2 Diabetes Mellitus: A Novel Epigenetic Effect

|Metabolites|2020|51